Study: Using a diabetes medication after testing positive for SARS-CoV-2 reduces risk of developing long COVID by 40% thelancet TheLancetInfDis
Taking a two-week course of metformin, a safe and affordable diabetes medication after testing positive for SARS-CoV-2 leads to 40% fewer long COVID diagnoses over the following 10 months, compared to individuals taking a placebo, finds a new study published inThe long-term symptoms some people experience after SARS-CoV-2 infection, known as long COVID, are an emerging chronic illness potentially affecting millions of people around the world.
Participants in the trial were not hospitalized, were at a higher risk of severe COVID-19 , over the age of 30, and had tested positive for SARS-CoV-2 within the last three days but had no known previous SARS-CoV-2 infection. Trial recruitment was open from December 2020 to January 2022 with 1,126 patients given either metformin or an identical placebo pill after testing positive for SARS-CoV-2 during that time.
Other arms of the trial looked at ivermectin and fluvoxamine and found that neither prevented long COVID.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Prenatal COVID boosts protective power of breast milkPrenatal COVID boosts protective power of breast milk BreastMilk ExtracellularVesicles SARSCoV MaternalHealth InfantDevelopment COVID MultiOmics MetabolicReprogramming MucosalTissue ImmuneModulation PostCOVID biorxivpreprint
Read more »
Driver crashes car after 'running out of talent' in 40-second police pursuitThe chase came to an abrupt end near Manchester Airport
Read more »
Leeds Beckett climbs 40 places as the Complete University Guide 2023 is releasedThe 2024 edition of the Complete University Guide sees the Leeds university make the biggest jump in the country on the list as it advances 40 places.
Read more »